<DOC>
	<DOCNO>NCT02266927</DOCNO>
	<brief_summary>To compare systemic exposure single dose 400 µg OPTINOSE FLUTICASONE 440 µg Flovent® HFA ( fluticasone propionate ) Inhalation Aerosol asthmatic subject .</brief_summary>
	<brief_title>A Study Compare Bioavailability Intranasal Administration 200 400 µg 400 µg Alone OPTINOSE™ FLUTICASONE With 440 µg Flovent® HFA ( Fluticasone Propionate ) Inhalation Aerosol ( Part 2 )</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone</mesh_term>
	<criteria>1 . Male female subject ' age 18 55 year , inclusive , screen . 2 . Have body mass index 18 32 kg/m2 , inclusive , body weight less 52 kg male 45 kg female . 3 . Otherwise healthy mild moderate asthmatic ( Part 2 ) clinically relevant abnormality opinion Investigator determine medical history , physical examination , blood chemistry , hematology ( include complete blood count ) , serology , urinalysis , vital sign , ECG perform screen . 4 . History mild moderate asthma , diagnosed physician , well control present time ( history sudden severe asthma exacerbation past 12 month ) . 5 . Are unlikely exacerbate study due seasonal allergen exposure . 6 . Able tolerate withdrawal medication require period time . 1 . Currently history disease dysfunction cardiovascular , endocrine , hematologic , neurological , immune , gastrointestinal , genitourinary , musculoskeletal , body system clinically significant opinion Investigator . 2 . History smoking use nicotinecontaining substance within previous 3 month screen . 3 . Hypersensitivity fluticasone propionate excipients find OPTINOSETM FLUTICASONE Flovent® HFA ( Part 2 ) . 4 . History extensive nasal and/or sinus surgery . 5 . Known nasal obstruction include allergic rhinitis , nasal septal deviation , polyposis , severe mucosal swell , nasal ulcer , nasal trauma reason . 6 . History acute severe asthma attack . 7 . History seasonal asthma exacerbation , case subject outside relevant allergen season . 8 . Have evidence chronic medical condition asthma require prescription medication ( e.g. , hypertension diabetes ) . 9 . Have use inhale , intranasal , oral , injectable corticosteroid within 4 week prior dose . Subjects stable treatment least 1 month prior withdrawal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>